Page last updated: 2024-09-03

imatinib mesylate and Sarcoma 180

imatinib mesylate has been researched along with Sarcoma 180 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aramaki, H; Furuyama, A; Higuchi, S; Koyanagi, S; Nakagawa, H; Nakamura, M; Ohdo, S; Takiguchi, T	1

Other Studies

1 other study(ies) available for imatinib mesylate and Sarcoma 180

Article	Year
Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice. Biochemical pharmacology, 2006, Nov-15, Volume: 72, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Benzamides; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Administration Schedule; Imatinib Mesylate; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Piperazines; Pyrimidines; Sarcoma 180	2006

Article

Year

Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice.

Biochemical pharmacology, 2006, Nov-15, Volume: 72, Issue:10

Topics: Angiogenesis Inhibitors; Animals; Benzamides; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Administration Schedule; Imatinib Mesylate; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Piperazines; Pyrimidines; Sarcoma 180

2006